[go: up one dir, main page]

DK1776358T3 - Substituerede propenylpiperazinderivater som nye inhibitorer af histondeacetylase - Google Patents

Substituerede propenylpiperazinderivater som nye inhibitorer af histondeacetylase

Info

Publication number
DK1776358T3
DK1776358T3 DK05777776T DK05777776T DK1776358T3 DK 1776358 T3 DK1776358 T3 DK 1776358T3 DK 05777776 T DK05777776 T DK 05777776T DK 05777776 T DK05777776 T DK 05777776T DK 1776358 T3 DK1776358 T3 DK 1776358T3
Authority
DK
Denmark
Prior art keywords
propenylpiperazine
derivatives
substituted
histone deacetylase
novel inhibitors
Prior art date
Application number
DK05777776T
Other languages
English (en)
Inventor
Brandt Sven F A Van
Emelen Kristof Van
Patrick R Angibaud
Laurence F B Marconnet-Decrane
Janine Janssen Pharmaceut Arts
Original Assignee
Janssen Pharmaceutica Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=39294123&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK1776358(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv
Application granted granted Critical
Publication of DK1776358T3 publication Critical patent/DK1776358T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/32One oxygen, sulfur or nitrogen atom
    • C07D239/42One nitrogen atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/06Antipsoriatics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/52Two oxygen atoms
    • C07D239/54Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
DK05777776T 2004-07-28 2005-07-25 Substituerede propenylpiperazinderivater som nye inhibitorer af histondeacetylase DK1776358T3 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP04077171 2004-07-28
US59235704P 2004-07-29 2004-07-29
PCT/EP2005/053611 WO2006010749A2 (en) 2004-07-28 2005-07-25 Substituted propenyl piperazine derivatives as novel inhibitors of histone deacetylase

Publications (1)

Publication Number Publication Date
DK1776358T3 true DK1776358T3 (da) 2009-09-07

Family

ID=39294123

Family Applications (1)

Application Number Title Priority Date Filing Date
DK05777776T DK1776358T3 (da) 2004-07-28 2005-07-25 Substituerede propenylpiperazinderivater som nye inhibitorer af histondeacetylase

Country Status (25)

Country Link
EP (1) EP1776358B1 (da)
JP (1) JP5279268B2 (da)
KR (1) KR101282833B1 (da)
CN (1) CN1993356B (da)
AR (1) AR050189A1 (da)
AT (1) ATE432274T1 (da)
AU (1) AU2005266311B2 (da)
BR (1) BRPI0513891B8 (da)
CA (1) CA2572971C (da)
CY (1) CY1110358T1 (da)
DE (1) DE602005014646D1 (da)
DK (1) DK1776358T3 (da)
EA (1) EA011932B1 (da)
ES (1) ES2327253T3 (da)
HR (1) HRP20090439T1 (da)
IL (1) IL180961A0 (da)
MX (1) MX2007001119A (da)
MY (1) MY142831A (da)
NO (1) NO20071117L (da)
NZ (1) NZ552758A (da)
PL (1) PL1776358T3 (da)
PT (1) PT1776358E (da)
SI (1) SI1776358T1 (da)
TW (1) TWI394752B (da)
WO (1) WO2006010749A2 (da)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2003218736B2 (en) 2002-03-13 2009-01-08 Janssen Pharmaceutica N.V. New inhibitors of histone deacetylase
US7767679B2 (en) 2002-03-13 2010-08-03 Janssen Pharmaceutica N.V. Sulfonylamino-derivatives as novel inhibitors of histone deacetylase
KR20040093692A (ko) 2002-03-13 2004-11-08 얀센 파마슈티카 엔.브이. 히스톤 디아세틸라제의 신규한 저해제로서의 피페라지닐-,피페리디닐- 및 모르폴리닐-유도체
KR101261305B1 (ko) 2004-07-28 2013-05-08 얀센 파마슈티카 엔.브이. 히스톤 디아세틸라제의 신규한 저해제로의 치환된 인돌릴알킬 아미노 유도체
DK1885710T3 (da) 2005-05-18 2015-11-23 Janssen Pharmaceutica Nv Substituerede aminopropenylpiperidin- eller morpholinderivater som hidtil ukendte inhibitorer af histondeacetylase
WO2007049262A1 (en) * 2005-10-27 2007-05-03 Berand Limited Methods and compositions for the promotion of neuronal growth and the treatment of asociality and affective disorders
HRP20090459T1 (hr) 2006-01-19 2009-09-30 Janssen Pharmaceutica N.V. Aminofenil derivati kao novi inhibitori histonskih deacetilaza
CN101370790B (zh) 2006-01-19 2015-10-21 詹森药业有限公司 作为组蛋白去乙酰化酶抑制剂的吡啶和嘧啶衍生物
EP1979327A1 (en) * 2006-01-19 2008-10-15 Janssen Pharmaceutica, N.V. Pyridine and pyrimidine derivatives as inhibitors of histone deacetylase
CA2635015C (en) 2006-01-19 2014-06-03 Janssen Pharmaceutica N.V. Substituted indolyl-alkyl-amino-derivatives as inhibitors of histone deacetylase
EP1839656A1 (en) * 2006-03-31 2007-10-03 TopoTarget Germany AG Use of valproic acid for the topical treatment of mild to moderate acne vulgaris
CA2703718A1 (en) * 2007-11-02 2009-05-07 Tammy Mallais Inhibitors of histone deacetylase
CN101723896B (zh) * 2009-11-03 2012-10-31 山东大学 酪氨酸衍生物类组蛋白去乙酰化酶抑制剂及其应用
WO2012117421A1 (en) 2011-03-02 2012-09-07 Orchid Research Laboratories Ltd Histone deacetylase inhibitors
KR101419836B1 (ko) * 2012-05-10 2014-07-16 서울대학교산학협력단 Δ5-2-옥소피페라진 유도체를 포함하는 중간엽 줄기세포의 연골세포로의 분화 유도용 조성물
KR101586045B1 (ko) 2013-07-30 2016-01-15 충북대학교 산학협력단 신규 페닐티아졸 기반 히드록삼산 및 이를 유효성분으로 포함하는 항암용 조성물
KR102132078B1 (ko) 2018-09-20 2020-07-08 원광대학교산학협력단 방향족 화합물, 아민 및 친핵체를 이용한 3가지 성분 반응으로 1-에틸-4-페닐피페라진 유도체를 제조하는 방법
KR102730905B1 (ko) 2022-05-03 2024-11-15 충북대학교 산학협력단 신규한 n-히드록시프로펜아미드 화합물 및 이를 유효성분으로 포함하는 암 예방 또는 치료용 약학적 조성물
KR102870919B1 (ko) 2022-05-03 2025-10-20 충북대학교 산학협력단 신규한 n-히드록시프로펜아미드 화합물 및 이를 유효성분으로 포함하는 암 예방 또는 치료용 약학적 조성물

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PH17194A (en) * 1980-03-06 1984-06-19 Otsuka Pharma Co Ltd Novel carbostyril derivatives,and pharmaceutical composition containing the same
AU2003218736B2 (en) * 2002-03-13 2009-01-08 Janssen Pharmaceutica N.V. New inhibitors of histone deacetylase
KR20040093692A (ko) * 2002-03-13 2004-11-08 얀센 파마슈티카 엔.브이. 히스톤 디아세틸라제의 신규한 저해제로서의 피페라지닐-,피페리디닐- 및 모르폴리닐-유도체
NZ536116A (en) * 2002-04-03 2007-01-26 Topotarget Uk Ltd Carbamic acid compounds comprising a piperazine linkage as HDAC inhibitors

Also Published As

Publication number Publication date
KR20070043978A (ko) 2007-04-26
DE602005014646D1 (de) 2009-07-09
TWI394752B (zh) 2013-05-01
EA200700143A1 (ru) 2007-06-29
WO2006010749A3 (en) 2006-06-08
AU2005266311B2 (en) 2011-08-11
EA011932B1 (ru) 2009-06-30
HRP20090439T1 (hr) 2009-09-30
EP1776358B1 (en) 2009-05-27
ES2327253T3 (es) 2009-10-27
AR050189A1 (es) 2006-10-04
AU2005266311A1 (en) 2006-02-02
JP2008508234A (ja) 2008-03-21
CY1110358T1 (el) 2015-04-29
HK1106236A1 (en) 2008-03-07
NO20071117L (no) 2007-02-27
TW200616998A (en) 2006-06-01
CA2572971C (en) 2013-01-15
BRPI0513891B8 (pt) 2021-05-25
MX2007001119A (es) 2007-03-15
MY142831A (en) 2011-01-14
CN1993356A (zh) 2007-07-04
EP1776358A2 (en) 2007-04-25
BRPI0513891B1 (pt) 2020-09-29
CA2572971A1 (en) 2006-02-02
BRPI0513891A (pt) 2008-05-20
PL1776358T3 (pl) 2009-10-30
WO2006010749A2 (en) 2006-02-02
CN1993356B (zh) 2010-10-27
NZ552758A (en) 2009-08-28
ATE432274T1 (de) 2009-06-15
JP5279268B2 (ja) 2013-09-04
IL180961A0 (en) 2007-07-04
SI1776358T1 (sl) 2009-10-31
KR101282833B1 (ko) 2013-07-08
PT1776358E (pt) 2009-08-13

Similar Documents

Publication Publication Date Title
DK1485348T3 (da) Carbonylamino-derivater som nye inhibitorer af histandeacetylase
DK1485354T3 (da) Sulfonylamino-derivater som nye inhibitorer af histandeacetylase
DK1485365T3 (da) Sulfonyl-derivater som nye inhibitorer af histandeacetylase
DK1485353T3 (da) Nye inhibitorer af histondeacetylase
DK1776358T3 (da) Substituerede propenylpiperazinderivater som nye inhibitorer af histondeacetylase
DK1981875T3 (da) Substituerede indolylalkylaminoderivater som inhibitorer af histondeacetylase
NO20044444L (no) Benzamidderivater nyttige som histondeacetylase inhibitorer
EP1789381A4 (en) INHIBITORS OF HISTONE DEACETYLASE
DK1501508T3 (da) Inhibitorer af histondeatylase
DK1848430T3 (da) Nye benzylamin-derivativer som cetp-inhibitors
DK2091945T3 (da) Nye inhibitorer af glutaminylcyclase
DK2086960T3 (da) Nye inhibitorer af glutaminylcyclase.
DK1485378T3 (da) Piperazinyl-, piperidinyl- og morpholinylderivater som nye inhibitorer af histondeacetylase
DK2081895T3 (da) Hydrobenzamidderivater som hæmmere af hsp90
DK1877379T3 (da) Hydroxybenzamidderivater og anvendelse heraf som inhibitorer af hsp90
BRPI0716838A2 (pt) combinaÇÕes de inibidores de histona deacetilase especÍfica de classe i com inibidores de proteosome
DK1979328T3 (da) Pyridin- og pyrimidinderivater i deres egenskab af histondeacetylasehæmmere
EP2265590A4 (en) SELECTIVE HISTONDEACETYLASE HEMMER
EP1991226A4 (en) Histone deacetylase INHIBITORS
DK2315756T3 (da) 1,2,5-oxadiazoler som inhibitorer af indolamin-2,3-dioxygenase
DK1789041T3 (da) Aryl-pyridinderivater som 11-beta-HSD1-inhibitorer
BRPI0817860A2 (pt) inibidores de histona deacetilase
EP2010168A4 (en) Histone deacetylase INHIBITORS
ZA200700763B (en) Substituted propenyl piperazine derivatives as novel inhibitors of histone deacetylase
DK1928872T3 (da) Hidtil ukendte sulfonylpyrroler som inhibitorer af hdac